Boardroom Alpha
Meeting calendar
FICO · Annual meeting · Wednesday, March 4, 2026

Fair Isaac Corp

8 nominees · 5 ballot items.

Elect eight directors; advisory approval of executive compensation; ratify Deloitte & Touche LLP as independent auditor; approve charter amendment to exculpate officers under Delaware law; approve charter amendment to eliminate supermajority voting requirement.

Market cap
$29.2B
1Y TSR
-24.6%
Board grade
B
Record date
Jan 5, 2026
Filing
DEF 14A
Meeting concluded · Mar 4, 2026

Follow how the vote landed and what changed on Fair Isaac Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot5

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of eight directors to serve until the 2027 Annual Meeting and until their successors are elected and qualified.

  2. 2

    Advisory Vote to Approve Executive Compensation

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the company’s named executive officers as disclosed in the proxy statement.

    More detail

    This proposal asks stockholders to cast a non-binding advisory vote to approve the disclosed compensation of the named executive officers. Management is presenting this to solicit stockholder feedback on its pay practices; the LDCC emphasizes a pay-for-performance philosophy, with a large portion of compensation delivered via performance-based and long-term equity awards tied to Adjusted Revenue, Adjusted EBITDA, and relative TSR metrics. The board recommends FOR, arguing the program aligns executive incentives with long-term stockholder interests, incorporates quality pay practices (clawbacks, minimum vesting, stock ownership guidelines, no hedging), and uses independent consultants. The outcome is advisory only but will be considered by the LDCC in future compensation decisions. The proposal should be evaluated in light of the company’s strong FY2025 financial performance, substantial equity awards to executives (including large PSUs and MSUs), and recent pay outcomes where CEO pay is highly concentrated in equity; potential concerns include the scale of CEO awards and their sensitivity to stock price volatility, retention-focused features, and double-trigger change-in-control protections.

  3. 3

    Ratification of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for fiscal 2026.

  4. 4

    Amendment to Restated Certificate of Incorporation to Allow for Exculpation of Officers

    ManagementBoard: FOR

    Approve an amendment to the Restated Certificate of Incorporation to add an Article allowing exculpation of officers for monetary damages for breaches of the duty of care as permitted by Delaware law, subject to specified exceptions.

    More detail

    Management requests stockholder approval to amend the charter to permit exculpation of certain officers from monetary damages for breaches of the duty of care, in line with Delaware's Section 102(b)(7). The proposal adds a new Article 8 specifying that officers will not be liable for monetary damages for duty of care breaches except for duty of loyalty breaches, acts not in good faith or involving intentional misconduct or knowing legal violations, transactions where the officer obtained an improper personal benefit, or derivative actions. The board argues the change mitigates exposure to hindsight-driven claims, limits litigation and insurance costs, and aids recruitment and retention of senior executives. Analysts should weigh the potential governance tradeoffs: while the amendment narrows exculpation to direct duty-of-care claims and preserves accountability for bad faith and loyalty breaches, it could reduce remedies available in some officer misconduct cases and may be scrutinized by governance-focused investors. Its adoption should be considered in tandem with the company’s other governance practices, insurance coverage, and the specific language which limits the scope to direct claims only.

  5. 5

    Amendment to Restated Certificate of Incorporation to Eliminate the Supermajority Voting Requirement

    ManagementBoard: FOR

    Approve an amendment to eliminate the existing supermajority (66-2/3%) voting requirement in Article 6(d) so that amendments to Article 6 can be made by a majority vote of outstanding shares.

    More detail

    Management proposes removing Article 6(d) which imposes a 66-2/3% supermajority requirement to amend Article 6, thereby restoring a default majority-vote standard for charter amendments. The board argues the change modernizes governance, eliminates an entrenched supermajority barrier, and aligns the company with common practice, enhancing shareholder democracy and operational flexibility. From a governance perspective, removal reduces minority protections against charter changes, potentially facilitating future amendments that could affect shareholder rights; however, management frames it as removing an outdated provision that is no longer necessary, particularly given other governance safeguards and the company’s independent board structure. The amendment would become effective upon filing a Certificate of Amendment with Delaware if approved.

Director elections

Nominees on the ballot8

Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC6.5%1,502,394$1.6B
2VANGUARD PORTFOLIO MANAGEMENT LLC5.4%1,255,488$1.3B
3Capital Research Global Investors4.8%1,119,457$1.2B
4BlackRock, Inc.4.6%1,061,506$1.1B
5STATE STREET CORP4.5%1,043,493$1.1B
6Valley Forge Capital Management, LP3.3%769,342$821M
7Capital World Investors3.2%732,665$782M
8Capital International Investors3.1%709,120$757M
9GEODE CAPITAL MANAGEMENT, LLC2.9%663,009$707M
10EDGEWOOD MANAGEMENT LLC2.3%537,515$574M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Fair Isaac Corp 2026 annual meeting?
Fair Isaac Corp (FICO) holds its 2026 annual shareholder meeting on Wednesday, March 4, 2026.
What is the record date for the Fair Isaac Corp 2026 meeting?
The record date for the Fair Isaac Corp 2026 meeting is Monday, January 5, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Fair Isaac Corp's 2026 meeting?
The board is presenting 8 director nominees at the Fair Isaac Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Fair Isaac Corp 2026 meeting?
Shareholders will vote on 5 proposals at the Fair Isaac Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer